It is widely accepted that the EGFR pathway, as well as downstream networks involving MEK‐ERK and PI3K‐AKT, was hyperactivated and played important roles in promoting tumour metastasis of multiple cancers, including HCC.29, 37, 38. Here, AKT1 is linked to hepatocellular carcinoma.